Trial Profile
Efficacy and Safety of Etanercept (Etn) in Patients with Moderately Active Rheumatoid Arthritis (Ra) Despite Disease-Modifying Antirheumatic Drug (Dmard) Therapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Aug 2016
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Disease-modifying antirheumatics
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 15 Dec 2014 New trial record